Search company, investor...

Monebo Technologies

monebo.com

Founded Year

2002

Stage

Series B | Alive

Total Raised

$500K

About Monebo Technologies

Monebo Technologies is dedicated to providing patients, physicians and partner companies with exceptional technology designed to increase the quality and efficiency of cardiac care. Singularly focused on the heart and more specifically its' electrical activity, the company strive to deliver high quality products and services that meet the needs of the company's customers today, and to be on the of technology development for tomorrow.

Headquarters Location

1800 Barton Creek Boulevard

Austin, Texas, 78735,

United States

512-732-0235

Monebo Technologies's Product Videos

Compete with Monebo Technologies?

Ensure that your company and products are accurately represented on our platform.

Monebo Technologies's Products & Differentiators

    Kinetic Algorithms

    The software which is used to measure, monitor and interpret the cardiac signals

Latest Monebo Technologies News

Dictum Health Welcomes Monebo as Partner in Telehealth Innovation

Feb 11, 2016

What ONC Got Wrong in their Guidance on Telehealth Dictum Health, Inc., a new medical device company with cross-industry expertise to provide the next evolution in the continuum of care, announced today a partnership with Monebo Technologies, Inc., a leader in mobile cardiac care via ECG signal processing. Dictum Health will incorporate Monebo’s ECG algorithm processing and interpretation technology in its new telehealth solution, a mobile and cloud-based platform that supports virtual and remote care for U.S. and global markets. Monitoring ECG signals with continual accuracy is critical in managing cardiac disease and giving providers and patients real-time data to guide clinical decisions. Monebo’s ECG algorithms work seamlessly with Dictum Health’s platform to establish a new telehealth model that supports clinical care anytime, anywhere. Monebo joins a select group of Dictum Health partners to create a new, integrated telehealth solution for the next evolution in the continuum of care. “Dictum’s mobile and cloud-based platform will accelerate the shift to a patient-centered, virtual care model that supports population health,” said Dale Misczynski, President and CEO of Monebo. “We’re pleased to join Dictum Health in pioneering the next frontier of telehealth.” “Improving patient outcomes is our goal,” said Elizabeth Keate, Vice President of Product Management at Dictum Health. “By collaborating with best-in-class partners like Monebo, Dictum Health will help change the way care is delivered with a more efficient and effective monitoring addressing the mobile patient.” About Monebo Monebo is focused on providing solutions to allow patients and physicians to manage and reduce problems associated with cardiac disease, and has developed technology for cardiac monitoring, homecare and pharmaceutical cardiac safety trials. Monebo’s proprietary digital signal-processing algorithms, highly developed sensor technology, and wireless communication capabilities provide medical device developers and original equipment manufacturers accurate real-time monitoring information, with increased patient mobility. For more information visit www.monebo.com . About Dictum Health Dictum Health Inc., with offices in Oakland, Calif., Portsmouth, N.H. and Dubai, UAE, pioneers next-generation, mobile and cloud-based telehealth solutions that connect physicians, patients and other members of the care team. Built upon a HIPAA compliant, cyber-secure platform, the secure Virtual Exam Room with simultaneous real-time health-data streaming provides in-office exam quality for clinical care anytime, anywhere. For more information visit www.dictumhealth.com . View source version on businesswire.com: http://www.businesswire.com/news/home/20160211005364/en/ Dictum Health, Inc.

Monebo Technologies Frequently Asked Questions (FAQ)

  • When was Monebo Technologies founded?

    Monebo Technologies was founded in 2002.

  • Where is Monebo Technologies's headquarters?

    Monebo Technologies's headquarters is located at 1800 Barton Creek Boulevard, Austin.

  • What is Monebo Technologies's latest funding round?

    Monebo Technologies's latest funding round is Series B.

  • How much did Monebo Technologies raise?

    Monebo Technologies raised a total of $500K.

  • Who are the investors of Monebo Technologies?

    Investors of Monebo Technologies include Fairway Medical Technologies, Texas Emerging Technology Fund, New Haven Trust, Austin Technology Incubator and Vesalius Ventures.

  • Who are Monebo Technologies's competitors?

    Competitors of Monebo Technologies include BPL Medical Technologies and 1 more.

  • What products does Monebo Technologies offer?

    Monebo Technologies's products include Kinetic Algorithms .

  • Who are Monebo Technologies's customers?

    Customers of Monebo Technologies include Artella Solutions.

Compare Monebo Technologies to Competitors

BPL Medical Technologies Logo
BPL Medical Technologies

BPL Medical Technologies manufactures healthcare equipment including electrocardiographs, patient monitors, defibrillators, central nursing stations, stress test systems, oxygenerators, ultrasound scanners, colposcopes and more.

C
Corscience

Corscience offers a range of medical devices and systems for use in clinical, preclinical, and homecare application as well as for clinical studies. It provides engineering services, module and license solutions, approval, and more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.